ROTHSCHILD & CO ASSET MANAGEMENT US INC. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 134 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROTHSCHILD & CO ASSET MANAGEMENT US INC. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$4,524,000
-1.1%
224,946
-7.8%
0.06%
-29.3%
Q3 2020$4,573,000
-28.6%
243,909
-14.5%
0.08%
-12.8%
Q2 2020$6,409,000
+51.9%
285,345
+0.4%
0.09%
+42.4%
Q1 2020$4,219,000
-34.5%
284,328
-14.8%
0.07%
-1.5%
Q4 2019$6,439,000
-6.5%
333,789
-3.9%
0.07%
-10.7%
Q3 2019$6,887,000
-6.1%
347,307
-0.1%
0.08%
-3.8%
Q2 2019$7,336,000
+14.5%
347,523
+10.8%
0.08%
+13.0%
Q1 2019$6,406,000
-4.2%
313,566
-6.7%
0.07%
-14.8%
Q4 2018$6,685,000
+7.8%
335,930
+4.3%
0.08%
+26.6%
Q3 2018$6,199,000
+23.5%
322,173
-2.0%
0.06%
+18.5%
Q2 2018$5,018,000
-15.2%
328,841
+4.2%
0.05%
-18.2%
Q1 2018$5,919,000
-5.7%
315,684
-3.3%
0.07%0.0%
Q4 2017$6,279,000
-0.8%
326,337
-7.8%
0.07%
-5.7%
Q3 2017$6,327,000
-1.8%
354,053
-1.8%
0.07%
-4.1%
Q2 2017$6,440,000
-28.9%
360,580
-42.3%
0.07%
-29.8%
Q1 2017$9,056,000624,5540.10%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders